Screener
McKesson MCK Prescription Technology Solutions — Goodwill acquired
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | North American Pharmaceutical | Oncology & Multispecialty | Prescription Technology Solutions | Medical-Surgical Solutions | Total |
|---|---|---|---|---|---|
| Balance, March 31, 2026 | $2,781 | $3,963 | $2,065 | $2,507 | $11,316 |
| Goodwill acquired | — | 13 | — | — | 13 |
| Disposals | — | (2) | — | — | (2) |
| Foreign currency translation adjustments, net | (26) | — | — | — | (26) |
| Other adjustments (1) | — | (23) | — | — | (23) |
| Balance, June 30, 2026 | $2,755 | $3,951 | $2,065 | $2,507 | $11,278 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's prescription technology solutions — goodwill acquired?
- McKesson (MCK) reported prescription technology solutions — goodwill acquired of $0 in Q2 2026.
- How has McKesson's prescription technology solutions — goodwill acquired changed year-over-year?
- McKesson's prescription technology solutions — goodwill acquired decreased by 100.0% year-over-year, from $39M to $0.
- What does prescription technology solutions — goodwill acquired mean?
- Tracks the addition of new goodwill to the balance sheet resulting from recent acquisitions within the Prescription Technology Solutions segment. This metric highlights the company's current strategy regarding inorganic growth and market expansion.
Ask your AI about McKesson's prescription technology solutions — goodwill acquired.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude